Long-term safety and efficacy of MBA-P01 for the treatment of glabellar lines: results from a multicenter, repeated-dose, open-label extension study

被引：1

作者：

Han, Hye Sung ^{[1
]}

Kim, Won-Serk ^{[2
]}

Lee, Yang Won ^{[3
]}

Won, Chong Hyun ^{[4
]}

Lee, Wooshun ^{[5
]}

Choi, Sun Young ^{[1
]}

Kim, Beom Joon ^{[6
]}

机构：

[1] Chung Ang Univ, Coll Med, Dept Dermatol, Gwangmyeong Hosp, Anseong, Gyeonggi Do, South Korea

[2] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Dermatol, Seoul, South Korea

[3] Konkuk Univ, Sch Med, Dept Dermatol, Seoul, South Korea

[4] Univ Ulsan, Coll Med, Dept Dermatol, Asan Med Ctr, Seoul, South Korea

[5] Medytox Inc, Seoul, South Korea

[6] Chung Ang Univ, Chung Ang Univ Hosp, Dept Dermatol, Coll Med, Seoul, South Korea

来源：

JOURNAL OF DERMATOLOGICAL TREATMENT | 2024年 / 35卷 / 01期

关键词：

Glabellar lines; botulinum toxin; new botulinum toxin (MBA-P01); long-term safety; open-label extension study; TOXIN TYPE-A; BOTULINUM; PTOSIS; INJECTION;

D O I：

10.1080/09546634.2024.2418919

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Clinical trial registration information: This study is registered in ClincalTrials.gov (NCT05321979).

引用

页数：8

共 20 条

[1] Unilateral transient mydriasis and ptosis after botulinum toxin injection for a cosmetic procedure [J].

Akkaya, Sezen ;

Kokcen, Hatice Kubra ;

Atakan, Tugba .

CLINICAL OPHTHALMOLOGY, 2015, 9 :313-315

[2] DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 andSAKURA 2) [J].

Bertucci, Vince ;

Solish, Nowell ;

Kaufman-Janette, Joely ;

Yoelin, Steve ;

Shamban, Ava ;

Schlessinger, Joel ;

Snyder, Daniel ;

Gallagher, Conor ;

Liu, Yan ;

Shears, Gill ;

Rubio, Roman G. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (04) :838-845

[3] The Convergence of Medicine and Neurotoxins: A Focus on Botulinum Toxin Type A and Its Application in Aesthetic MedicineA Global, Evidence-Based Botulinum Toxin Consensus Education Initiative [J].

Carruthers, Jean ;

Fournier, Nathalie ;

Kerscher, Martina ;

Ruiz-Avila, Javier ;

Trindade de Almeida, Ada R. ;

Kaeuper, Gina .

DERMATOLOGIC SURGERY, 2013, 39 (03) :510-525

[4] Safety of Botulinum Toxin A in Aesthetic Treatments: A Systematic Review of Clinical Studies [J].

Cavallini, Maurizio ;

Cirillo, Pierfrancesco ;

Fundaro, Salvatore Piero ;

Quartucci, Sandro ;

Sciuto, Chantal ;

Sito, Giuseppe ;

Tonini, Davide ;

Trocchi, Gloria ;

Signorini, Massimo .

DERMATOLOGIC SURGERY, 2014, 40 (05) :525-536

[5]

Cox Sue Ellen, 2005, International Ophthalmology Clinics, V45, P13, DOI 10.1097/01.iio.0000167237.49396.7b

[6]

Dayan Steven, 2019, Aesthet Surg J Open Forum, V1, pojz015, DOI [10.1093/asjof/ojz015, 10.1093/asjof/ojz015]

[7] Social implications of hyperfunctional facial lines [J].

Finn, JC ;

Cox, SE ;

Earl, ML .

DERMATOLOGIC SURGERY, 2003, 29 (05) :450-455

[8] Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A - Basis for distinct durations of inhibition of exocytosis in central neurons [J].

Foran, PG ;

Mohammed, N ;

Lisk, GO ;

Nagwaney, S ;

Lawrence, GW ;

Johnson, E ;

Smith, L ;

Aoki, KR ;

Dolly, JO .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (02) :1363-1371

[9] Pharmacologic denervation of frown muscles enhances baseline expression of happiness and decreases baseline expression of anger, sadness, and fear [J].

Heckmann, M ;

Teichmann, B ;

Schröder, U ;

Sprengelmeyer, R ;

Ceballos-Baumann, AO .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (02) :213-216

[10]

Jeong S, 1999, ARCH OPHTHALMOL-CHIC, V117, P907

← 1 2 →